Jakob Loven, Ph.D.
Partner, Nextech Invest
Jakob Loven, Ph.D., is an accomplished oncology-focused entrepreneur and life science venture capitalist, currently working as a partner at Nextech Invest Ltd. Jakob utilizes his extensive experience to create, launch and build early stage therapeutic-based platform biotechnology companies, which have included Relay Therapeutics and Syros Pharmaceuticals. Jakob also serves as a board member of Arvinas, Vividion, Arrakis and Kronos.